share_log

小林製薬---大幅続伸、紅こうじ問題収束と判断し国内証券では買い推奨に格上げ

Kobayashi Pharmaceutical Co., Ltd. - significant increase, upgrading to buy recommendation by domestic securities firms based on the assessment of resolving the red koji issue.

Fisco Japan ·  Nov 25, 2024 12:08

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment